EN

科研队伍

您现在的位置: 首页> 科研队伍> 副研究员

副研究员

叶军

职 称:副研究员

所属科室:药物制剂研究室

导师类别:博士生导师

联系方式:yelinghao@imm.ac.cn

所属重点实验室:药物传输技术及新型制剂北京市重点实验室

研究方向

1. 智能纳米递送系统靶向肿瘤免疫治疗;
2. 创新雾化吸入纳米平台用于呼吸道疾病精准干预;
3. 生物活性高分子基多功能水凝胶用于皮肤修复抗衰;
4. 多功能无机纳米探针实现疾病诊疗一体化。

发表论文

1. Jun Ye (co-corresponding author). A minimalist self-assembly nanosystem for cancer immunotherapy via multiple immune activation. Journal of Nanobiotechnology 2025, 23 (1):410.
2. Jun Ye (co-corresponding author). A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers. Acta Pharm Sin B 2025.
3. Jun Ye (co-corresponding author). Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy. J Nanobiotechnology 2025, 23 (1):161.
4. Jun Ye (co-corresponding author). Bioactive metallic nanoparticles for synergistic cancer immunotherapy. Acta Pharm Sin B 2025.
5. Jun Ye (co-corresponding author). Multifunctional Hydrogel Based on Silk Fibroin Promotes Tissue Repair and Regeneration. Adv Funct Mater 2024, 34 (39):2405255.
6. Jun Ye (co-corresponding author). Simple and versatile in situ thermo-sensitive hydrogel for rectal administration of SZ-A to alleviate inflammation and repair mucosal barrier in ulcerative colitis. Chin Chem Lett 2024, 35 (6):109736.
7. Jun Ye (co-corresponding author). Advanced Bioinspired Multifunctional Platforms Focusing on Gut Microbiota Regulation. ACS Nano 2024, 18 (32):20886-20933.
8. Jun Ye (co-corresponding author). Supramolecular-orchestrated carrier-free chemodynamic synergists with augmented oxidative damage for potentiated cancer therapy. Chin Chem Lett 2024:110765.
9. Jun Ye (co-corresponding author). Unlocking the potential of amorphous calcium carbonate: A star ascending in the realm of biomedical application. Acta Pharm Sin B 2024, 14 (2):602-622.
10. Jun Ye (co-corresponding author). Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: Focus on underlying mechanisms and future perspectives. Chin Chem Lett 2024, 35 (2):109074.
11. Jun Ye (first author). Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations. J Nanobiotechnology 2021, 19 (1):199.
12. Jun Ye (first author). Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity. J Immunother Cancer 2021, 9 (7):e002753.
13. Jun Ye (co-first author). Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma. Bioact Mater 2020, 5 (3):694-708.
14. Jun Ye (co-first author). Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein. Acta Pharm Sin B 2020, 10 (8):1576-1585.